Compare Mutual Funds
Select a Mutual Fund
Risk | Very High | - |
Rating | 5.0 | - |
Min SIP Amount | ₹100 | - |
Expense Ratio | 1.86 | - |
NAV | ₹38.69 | - |
Fund Started | 25 Jun 2018 | - |
Fund Size | ₹6455.55 Cr | - |
Exit Load | Exit load of 1% if redeemed within 15 days. | - |
Risk
Very High
-
Rating
5.0
-
Min SIP Amount
₹100
-
Expense Ratio
1.86
-
NAV
₹38.69
-
Fund Started
25 Jun 2018
-
Fund Size
₹6455.55 Cr
-
Exit Load
Exit load of 1% if redeemed within 15 days.
-
1 Year | 1.79% | - |
3 Year | 26.35% | - |
5 Year | 16.49% | - |
1 Year
1.79%
-
3 Year
26.35%
-
5 Year
16.49%
-
Equity | 97.87% | - |
Cash | 2.13% | - |
Equity
97.87%
-
Cash
2.13%
-
Top 10 Holdings |
| - |
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 12.05% |
Cipla Ltd. | 7.90% |
Dr. Reddy's Laboratories Ltd. | 7.82% |
Divi's Laboratories Ltd. | 7.10% |
Mankind Pharma Ltd. | 6.44% |
Lupin Ltd. | 5.78% |
Aurobindo Pharma Ltd. | 5.19% |
Alkem Laboratories Ltd. | 3.66% |
Cohance Lifesciences Ltd. | 3.01% |
Syngene International Ltd. | 2.98% |
-
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. | - |
Launch Date | 25 Jun 2018 | - |
Description
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
-
Launch Date
25 Jun 2018
-